Rezolute Announces $30 Million Debt Financing Agreement with SLR Capital Partners
REDWOOD CITY, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “the Company”) (Nasdaq: RZLT), a clinical stage...
News
Immutep Quarterly Activities Report
Highlights Safely dosed the last HNSCC patient for Stage 2 of Part C of the TACTI-002 Phase II study (also...
University of Miami Health System and One Medical Announce Affiliation Focused on Seamless Coordinated Care
One Medical plans to bring its technology-powered primary care model to FloridaMIAMI and SAN FRANCISCO, April 19, 2021 (GLOBE NEWSWIRE)...
Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results
2021: Executing on Opportunities and Preparing for the FutureFRAMINGHAM, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:...
CERiS Offers First Prepayment Dual Reviews For Payment Integrity Programs
Itemized Bill Review and DRG Validation Are Performed by a Division of a Publicly Traded Company, Independent from Ongoing Market...
Therma Bright Announces EU-CE Approval for AcuVid(TM) COVID-19 Rapid Antigen Saliva Test and Conditional Sale for 100,000 CE-only AcuVid(TM) Test Kits
New global distribution partner McWilliams Collective secures test kit order from European clientToronto, Ontario--(Newsfile Corp. - April 19, 2021) -...
Embark Delta Inc. Completes Additional Shipment to Province of Ontario
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark"...
Embark Delta Inc. Completes First Shipment to Province of Saskatchewan
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark"...
LivaNova Achieves Clinical Milestone in Heart Failure Program
300th patient randomized in ANTHEM-HFrEF pivotal study LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced...
AgNovos Healthcare Receives Investigational Device Exemption (IDE) for Breakthrough Spine Device
NEW YORK--(BUSINESS WIRE)--AgNovos Healthcare, a developer of medical technology products leveraging regenerative medicine to treat the local effects of bone...
CareLineLive secures £1.2 million funding to support digitalisation and innovation within the homecare sector
Led by Haatch Ventures, the investment will support CareLineLive’s international expansion and grow headcount London, UK; 19th April 2021: CareLineLive,...
Evotec enters partnership with Kazia Therapeutics for clinical development of EVT801
EVOTEC GRANTS KAZIA THERAPEUTICS AN EXCLUSIVE WORLDWIDE LICENSE FOR DEVELOPMENT AND COMMERCIALISATION OF ONCOLOGY ASSET EVT801 KAZIA INTENDS TO INITIATE...
Relief Comments on Certain Statements Made by NeuroRx, Inc. in the Amended Form S-4 Filing of Big Rock Partners Acquisition Corp.
GENEVA, SWITZERLAND / ACCESSWIRE / April 19, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief" or the "Company"), commented today...
VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE Study Presented as Late-Breaking Science at ESC Preventive Cardiology 2021
Study quantified coronary plaque changes in patients administered 4 g/day of VASCEPA® (icosapent ethyl) on top of statin therapy Effect...
Core One Labs Negotiates Milestone Acquisition With Akome Biotech Ltd.
VANCOUVER, BC / ACCESSWIRE / April 17, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the "Company") a biotechnology research...
Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers
Elucid Software Quantifies Plaque Morphology to Enable Better Assessment of IPE Treatment Effects BOSTON--(BUSINESS WIRE)--Elucid, a medical technology company developing...
Avadel Presents New Data from its Pivotal REST-ON Phase 3 Trial of FT218, once-nightly sodium oxybate, at the 2021 American Academy of Neurology Annual Meeting
Secondary endpoint data for once-nightly FT218 further supports previously announced topline data demonstrating clinically meaningful results at 6 g, 7.5...
Jupiter Wellness to Support Growth in CBD-Based Pharma & Consumer Products
JUPITER, FL / ACCESSWIRE / April 16, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based...
Leveljump Announces Fiscal 2020 Earnings and Results
Toronto, Ontario--(Newsfile Corp. - April 16, 2021) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), a Canadian leader...
Alkame Holdings, Inc. Announces Corporate Update
LAS VEGAS, NV / ACCESSWIRE / April 16, 2021 / Alkame Holdings, Inc. (OTC PINK:ALKM), is pleased to provide an...